Cargando…
The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577817/ http://dx.doi.org/10.1186/1742-4690-12-S1-P10 |
_version_ | 1782391021984808960 |
---|---|
author | Harrod, Robert Romeo, Megan Malu, Aditi Hutchison, Tetiana White, Averi Gardner, Rachel Nguyen, Olivia Hazen, Catherine Rao, Neha |
author_facet | Harrod, Robert Romeo, Megan Malu, Aditi Hutchison, Tetiana White, Averi Gardner, Rachel Nguyen, Olivia Hazen, Catherine Rao, Neha |
author_sort | Harrod, Robert |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4577817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45778172015-09-23 The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation Harrod, Robert Romeo, Megan Malu, Aditi Hutchison, Tetiana White, Averi Gardner, Rachel Nguyen, Olivia Hazen, Catherine Rao, Neha Retrovirology Poster Presentation BioMed Central 2015-08-28 /pmc/articles/PMC4577817/ http://dx.doi.org/10.1186/1742-4690-12-S1-P10 Text en Copyright © 2015 Harrod et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Harrod, Robert Romeo, Megan Malu, Aditi Hutchison, Tetiana White, Averi Gardner, Rachel Nguyen, Olivia Hazen, Catherine Rao, Neha The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation |
title | The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation |
title_full | The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation |
title_fullStr | The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation |
title_full_unstemmed | The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation |
title_short | The HTLV-1 latency-maintenance factor p30II activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation |
title_sort | htlv-1 latency-maintenance factor p30ii activates p53-dependent metabolic effectors to promote oncogene-activation and aberrant lymphoproliferation |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577817/ http://dx.doi.org/10.1186/1742-4690-12-S1-P10 |
work_keys_str_mv | AT harrodrobert thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT romeomegan thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT maluaditi thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT hutchisontetiana thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT whiteaveri thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT gardnerrachel thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT nguyenolivia thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT hazencatherine thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT raoneha thehtlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT harrodrobert htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT romeomegan htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT maluaditi htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT hutchisontetiana htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT whiteaveri htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT gardnerrachel htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT nguyenolivia htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT hazencatherine htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation AT raoneha htlv1latencymaintenancefactorp30iiactivatesp53dependentmetaboliceffectorstopromoteoncogeneactivationandaberrantlymphoproliferation |